# Multiple Myeloma Management

> Medical

Canonical page: [https://chrome-stats.com/d/id6449560414](https://chrome-stats.com/d/id6449560414)

## Overview

- **ID:** `id6449560414`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** Med Learning Group
- **Category:** Medical
- **Version:** 1.0
- **Last updated:** 2023-05-26
- **First published:** 2023-05-26
- **Size:** 90 MB
- **Data as of:** 2026-09-06
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/multiple-myeloma-management/id6449560414)
- **Privacy policy:** [http://www.medlearninggroup.com/privacy-policy/](http://www.medlearninggroup.com/privacy-policy/)

## Description

This program discusses relapsed/refractory multiple myeloma and role of BCMA therapies

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.

## Rankings

- #1,155,204 — Overall

## Similar extensions and apps

- [Myeloma BsAb iAR](https://chrome-stats.com/d/id6755856552)
- [Multiple Myeloma \[MM\]](https://chrome-stats.com/d/id637863661) — 5.00 / 5
- [AllThingsMyeloma](https://chrome-stats.com/d/id6756783209)
- [Multiple Myeloma Manager](https://chrome-stats.com/d/id869026450) — 4.00 / 5
- [MDS Clear Path](https://chrome-stats.com/d/id6476326900)
- [Mieloma Múltiple @Point of Care™](https://chrome-stats.com/d/id900108634)
- [Myeloma Monitor](https://chrome-stats.com/d/id1458499018) — 3.00 / 5
- [Shaping the Future of NMSC](https://chrome-stats.com/d/id6746297272)
- [BC Collaborative](https://chrome-stats.com/d/id6670310298) — 5.00 / 5
- [Multiples Myelom onkowissen](https://chrome-stats.com/d/id1428874356)
- [MDS Center](https://chrome-stats.com/d/id1277615573)
- [My Multiple Myeloma](https://chrome-stats.com/d/id6608973603)

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id6449560414)
